Physician profile
Eliot Friedman
NPI 1962453092
$244.47
in general payments reported to CMS, 2019-2025
12 companies · $14.11 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $45.02 · 2023: $15.32 · 2024: $45.14 · 2025: $14.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.25 · Education: $15.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.25 |
| Education | $15.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $59.25 | 2024-2025 | Smartvest |
| Genentech USA, INC. | $32.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.19 | 2020 | |
| Tactile Systems Technology INC | $20.83 | 2020 | |
| Astellas Pharma US INC | $20.11 | 2019 | |
| Lilly USA, LLC | $15.74 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.32 | 2023 | Opdivo |
| Exelixis INC. | $14.95 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.86 | 2019 | |
| Pfizer INC. | $14.54 | 2019 | |
| Merck Sharp & Dohme LLC | $11.75 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eliot Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.